Gilead nears up to $2bn deal for autoimmune biotech Ouro Medicines

By:
On:
URL has been copied successfully!
California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years
Please follow us:
Follow by Email
X (Twitter)
Whatsapp
LinkedIn
Copy link

This post was originally published here